Cagen (Biotechnology) is Biotechnology in United Kingdom that focus on excess toxicity business. Founded in 2017. They cover business area such as developer, biotechnology platform, payload, premature degradation, excess toxicity, molecule, compound, drug development, researcher, drug release, novel therapeutic approach, toxic side effect.
2017
( 7 years old in 2024 )
Excess Toxicity
-
Sir Alexander Fleming Building Imperial College London
South Kensington
London SW7 2AZ
England, United Kingdom
Private
developerbiotechnology platformpayloadpremature degradationexcess toxicitymoleculecompounddrug developmentresearcherdrug releasenovel therapeutic approachtoxic side effect
* We use standard office opening hours in near Cagen (Biotechnology)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cagen (Biotechnology) is Biotechnology business from United Kingdom that founded in 2017 (7 years old in 2024), Cagen (Biotechnology) business is focusing on Excess Toxicity.
Cagen (Biotechnology) headquarter office and corporate office address is located in Sir Alexander Fleming Building Imperial College London South Kensington London SW7 2AZ England, United Kingdom.
Cagen (Biotechnology) was founded in United Kingdom.
In 2024, Cagen (Biotechnology) is currently focus on excess toxicity sector.
Above is snippet of Google Trends for "excess toxicity" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cagen (Biotechnology), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
